NeoDynamics presents an abstract on pulse biopsy data for NeoNavia at the UK Association of Breast Surgeons Conference 2021
NeoDynamics AB (Spotlight Stock Market: NEOD), a MedTech company dedicated to advancing diagnosis and care of breast cancer, presents pre-clinical data in a poster session at the Association of Breast Surgeons (ABS) online Conference 2021, May 16th – 18th. The data presented in the abstract demonstrates that NeoDynamics FlexiPulse needle outperforms standard core needle biopsy in respect of sample yield in pre-clinical models by almost 300%.The abstract has been accepted for a poster presentation, titled “Novel pulse biopsy platform incorporating adaptive open-tip sampling needle increases